CorrlensCorrlens
Correlate

Correlation Analysis

Broadcom Inc. Common Stock vs Biogen Inc. Common Stock

AVGO vs BIIB

-0.724

Strong inverse

When one moves up, the other tends to move down.

AVGO logo

Broadcom Inc. Common Stock

AVGO

Broadcom is one of the largest semiconductor companies in the world and has also expanded into infrastructure software. Its semiconductors primarily serve computing and networking, with custom AI accelerators now accounting for the bulk of the business. It is primarily a fabless designer, but holds some manufacturing in-house, such as for its best-of-breed film bulk acoustic resonator filters that sell into the Apple iPhone. In software, it sells virtualization, infrastructure, and security software to large enterprises, financial institutions, and governments. Broadcom is the product of consolidation. Its businesses are an amalgamation of former companies like legacy Broadcom and Avago Technologies in chips, as well as VMware, Brocade, CA Technologies, and Symantec in software.

Market cap 1.5T

BIIB logo

Biogen Inc. Common Stock

BIIB

Biogen is an established biopharmaceutical company focused on treatments for neurodegenerative and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 40% of total revenue in 2025. Biogen also generates significant revenue from its CD20 collaboration agreements with Roche (19% of total in 2025), which includes oncology drugs Rituxan and Gazyva and multiple sclerosis drug Ocrevus. Biogen's newer franchises include Spinraza (spinal muscular atrophy, with partner Ionis), Leqembi (Alzheimer's disease, collabroation revenue from its partner Eisai), Skyclarys (Friedreich's ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (amyotrophic lateral sclerosis, Ionis).

Market cap 25.3B · 7,500 employees

Apr 9, 2021 — Apr 7, 2026Daily1,253 observationsStockStockTechnology

Time Series

Rebased to 100

Green: AVGOGray: BIIB36 of 1,253 points (sampled)

Who Moves First

BIIB leads AVGO by 6 days

BIIB tends to move before AVGO.

Best correlation after shifting: -0.729 (13 shifts scanned)

Do They Crash Together?

Correlation by Market Regime

How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.

Both Rising

-0.058

11 periods · Return correlation when both series rose

Both Falling

+0.226

7 periods · Return correlation when both series fell

Diverging

-0.481

17 periods · Return correlation when series moved apart

R-Squared

52.5%

Share of variance in one series explained by the other.

Trend Agreement

58.4%

How often both series moved in the same direction period-to-period.

Overlap Quality

1,253

Deep shared window — 1,253 usable pairs.

Significance

p < 0.001

95% CI: [-0.750, -0.697]

Scatter

XY Regression

20100200300400403102.6150200250300342.9Broadcom Inc. Common StockBiogen Inc. Common StockData pointsFit (r = -0.724)

Pipeline

Data quality details

Pipeline Summary

1,253 paired observations survived the daily window.

Raw input

1,254

1,253

Normalized

1,254

1,253

Prepared

1,254

1,253

Aligned

1,253

1,253

Invalid removed

0

A: 0 / B: 0

Duplicates removed

0

A: 0 / B: 0

Alignment drops

1

A: 1 / B: 0

Series A

AVGO logo

Broadcom Inc. Common Stock

AVGO

Market cap 1.5T

Stock · 1,254 raw → 1,254 prepared

Series B

BIIB logo

Biogen Inc. Common Stock

BIIB

Market cap 25.3B · 7,500 employees

Stock · 1,253 raw → 1,253 prepared

Sign agreement

100.0%

How often both values share the same sign.

Zero crossings

7

Estimated crossover points between normalized spreads.

Slope

-0.4318

Linear regression slope.

Intercept

282.2702

Linear regression intercept.

Related Extremes

Highest and Lowest Correlated

Saved 3 hours ago · ID: stock-avgo-vs-stock-biib-daily-20260408-yzj3rl